Jill Crosson, DO
Sports Medicine · Allentown, PANPI 1992936249
Payments from drug & device makers
Across 116 payments — averaging $31.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novus Surgical Solutions LLC$924
- Novus Surgical Consultants$725
- Johnson & Johnson$459
- Ferring Pharmaceuticals Inc.$453
- Arthrex$283
- Bioventus LLC$184
- plus $611 from 14 others
What the payments were for
- Consulting fees$52514%
- Travel & lodging$67419%
- Food & beverage$2,13859%
- Education$3008%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novus Surgical Solutions LLC | 4 | $924 |
| Novus Surgical Consultants | 12 | $725 |
| Johnson & Johnson | 27 | $459 |
| Ferring Pharmaceuticals Inc. | 30 | $453 |
| Arthrex | 3 | $283 |
| Bioventus LLC | 10 | $184 |
| Electronic Waveform Lab, Inc. | 11 | $154 |
| Arteriocyte Medical Systems, Inc. | 2 | $107 |
| ERMI LLC | 3 | $88 |
| Radius Health, Inc. | 3 | $65 |
| Vertex | 1 | $32 |
| Smith+Nephew | 2 | $27 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| Fidia Pharma USA Inc. | 1 | $21 |
| Amgen | 1 | $20 |
| Pacira Therapeutics, Inc. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Zimmer Biomet | 1 | $12 |
| Synergy Orthopedics, LLC | 1 | $11 |
How this compares
$3,637 in reported general payments places this provider in the 70th percentile of 311 sports medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 20 | $611 |
| Celecoxib | 32 | $426 |
| Ibuprofen | 18 | $126 |
| Meloxicam | 26 | $109 |
| Tramadol Hcl | 38 | $86 |
| Naproxen | 19 | $58 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Allentown
- Matthew BestAllentown$77K
- Robert PalumboAllentown$7K
- Sam AkhavanPittsburgh$2.3M
- Albert LinPittsburgh$503K
- Christopher MehalloPhiladelphia$485K
- David BizouskyIndiana$418K
- Theresa PazionisPhiladelphia$253K
- Philip GehrmanPhiladelphia$241K
- Sommer HammoudPhiladelphia$239K
- Matthew Varacallodu Bois$179K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.